Schedule of Additional Information Relating to All Outstanding Stock Options (Details) - USD ($) shares in Thousands |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Jun. 27, 2026 |
Mar. 28, 2026 |
Dec. 27, 2025 |
|
| Equity [Abstract] | |||
| Beginning balance | 20,000 | 20,000 | |
| Weighted average exercise price beginning balance | $ 3.83 | $ 3.83 | |
| Aggregate intrinsic value beginning balance | |||
| Weighted average remaining contractual life (in years) | 4 years 2 months 12 days | 4 years 4 months 24 days | 4 years 8 months 12 days |
| Ending balance | 20,000 | 20,000 | 20,000 |
| Weighted average exercise price ending balance | $ 3.83 | $ 3.83 | $ 3.83 |
| Aggregate intrinsic value ending balance | |||
| Exercisable balance | 20,000 | ||
| Weighted average exercise price exercisable | $ 3.83 | ||
| Aggregate intrinsic value exercisable balance | |||
| Weighted average remaining contractual life in years Exercisable | 4 years 2 months 12 days | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for vested portion of option outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for option award outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|